J Ivanidze1, O N Kallas2, A Gupta2, E Weidman2, H Baradaran2, D Mir2, A Giambrone3, A Z Segal4, J Claassen5, P C Sanelli2. 1. From the Departments of Radiology (J.I., O.N.K., A.Gupta, E.W., H.B., D.M., P.C.S.) jai9018@nyp.org. 2. From the Departments of Radiology (J.I., O.N.K., A.Gupta, E.W., H.B., D.M., P.C.S.). 3. Healthcare Policy and Research (A.Giambrone). 4. Neurology (A.Z.S.), Weill Cornell Medical College, New York-Presbyterian Hospital, New York, New York. 5. Department of Neurology (J.C.), New York-Presbyterian Hospital, Columbia University Medical Center, New York, New York.
Abstract
BACKGROUND AND PURPOSE: Blood-brain barrier permeability is not routinely evaluated in the clinical setting. Global cerebral edema occurs after SAH and is associated with BBB disruption. Detection of global cerebral edema using current imaging techniques is challenging. Our purpose was to apply blood-brain barrier permeability imaging in patients with global cerebral edema by using extended CT perfusion. MATERIALS AND METHODS: Patients with SAH underwent CTP in the early phase after aneurysmal rupture (days 0-3) and were classified as having global cerebral edema or nonglobal cerebral edema using established noncontrast CT criteria. CTP data were postprocessed into blood-brain barrier permeability quantitative maps of PS (permeability surface-area product), K(trans) (volume transfer constant from blood plasma to extravascular extracellular space), Kep (washout rate constant of the contrast agent from extravascular extracellular space to intravascular space), VE (extravascular extracellular space volume per unit of tissue volume), VP (plasmatic volume per unit of tissue volume), and F (plasma flow) by using Olea Sphere software. Mean values were compared using t tests. RESULTS: Twenty-two patients were included in the analysis. Kep (1.32 versus 1.52, P < .0001), K(trans) (0.15 versus 0.19, P < .0001), VP (0.51 versus 0.57, P = .0007), and F (1176 versus 1329, P = .0001) were decreased in global cerebral edema compared with nonglobal cerebral edema while VE (0.81 versus 0.39, P < .0001) was increased. CONCLUSIONS: Extended CTP was used to evaluate blood-brain barrier permeability in patients with SAH with and without global cerebral edema. Kep is an important indicator of altered blood-brain barrier permeability in patients with decreased blood flow, as Kep is flow-independent. Further study of blood-brain barrier permeability is needed to improve diagnosis and monitoring of global cerebral edema.
BACKGROUND AND PURPOSE: Blood-brain barrier permeability is not routinely evaluated in the clinical setting. Global cerebral edema occurs after SAH and is associated with BBB disruption. Detection of global cerebral edema using current imaging techniques is challenging. Our purpose was to apply blood-brain barrier permeability imaging in patients with global cerebral edema by using extended CT perfusion. MATERIALS AND METHODS:Patients with SAH underwent CTP in the early phase after aneurysmal rupture (days 0-3) and were classified as having global cerebral edema or nonglobal cerebral edema using established noncontrast CT criteria. CTP data were postprocessed into blood-brain barrier permeability quantitative maps of PS (permeability surface-area product), K(trans) (volume transfer constant from blood plasma to extravascular extracellular space), Kep (washout rate constant of the contrast agent from extravascular extracellular space to intravascular space), VE (extravascular extracellular space volume per unit of tissue volume), VP (plasmatic volume per unit of tissue volume), and F (plasma flow) by using Olea Sphere software. Mean values were compared using t tests. RESULTS: Twenty-two patients were included in the analysis. Kep (1.32 versus 1.52, P < .0001), K(trans) (0.15 versus 0.19, P < .0001), VP (0.51 versus 0.57, P = .0007), and F (1176 versus 1329, P = .0001) were decreased in global cerebral edema compared with nonglobal cerebral edema while VE (0.81 versus 0.39, P < .0001) was increased. CONCLUSIONS: Extended CTP was used to evaluate blood-brain barrier permeability in patients with SAH with and without global cerebral edema. Kep is an important indicator of altered blood-brain barrier permeability in patients with decreased blood flow, as Kep is flow-independent. Further study of blood-brain barrier permeability is needed to improve diagnosis and monitoring of global cerebral edema.
Authors: Edwin Bennink; Alan J Riordan; Alexander D Horsch; Jan Willem Dankbaar; Birgitta K Velthuis; Hugo W de Jong Journal: J Cereb Blood Flow Metab Date: 2013-07-24 Impact factor: 6.200
Authors: H Baradaran; V Fodera; D Mir; K Kesavabhotla; K Kesavobhotla; J Ivanidze; U Ozbek; A Gupta; J Claassen; P C Sanelli Journal: AJNR Am J Neuroradiol Date: 2015-05-14 Impact factor: 3.825
Authors: Jan Claassen; J Ricardo Carhuapoma; Kurt T Kreiter; Evelyn Y Du; E Sander Connolly; Stephan A Mayer Journal: Stroke Date: 2002-05 Impact factor: 7.914
Authors: P C Sanelli; I Ugorec; C E Johnson; J Tan; A Z Segal; M Fink; L A Heier; A J Tsiouris; J P Comunale; M John; P E Stieg; R D Zimmerman; A I Mushlin Journal: AJNR Am J Neuroradiol Date: 2011-09-29 Impact factor: 3.825
Authors: Elizabeth Nance; Kelsie Timbie; G Wilson Miller; Ji Song; Cameron Louttit; Alexander L Klibanov; Ting-Yu Shih; Ganesh Swaminathan; Rafael J Tamargo; Graeme F Woodworth; Justin Hanes; Richard J Price Journal: J Control Release Date: 2014-06-28 Impact factor: 9.776
Authors: P C Sanelli; N Anumula; C E Johnson; J P Comunale; A J Tsiouris; H Riina; A Z Segal; P E Stieg; R D Zimmerman; A I Mushlin Journal: AJNR Am J Neuroradiol Date: 2012-08-02 Impact factor: 3.825
Authors: P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff Journal: J Magn Reson Imaging Date: 1999-09 Impact factor: 4.813
Authors: J Ivanidze; R A Charalel; I Shuryak; D Brenner; A Pandya; O N Kallas; K Kesavabhotla; A Z Segal; M S Simon; P C Sanelli Journal: AJNR Am J Neuroradiol Date: 2017-01-12 Impact factor: 3.825
Authors: J M Chi; M Mackay; A Hoang; K Cheng; C Aranow; J Ivanidze; B Volpe; B Diamond; P C Sanelli Journal: AJNR Am J Neuroradiol Date: 2019-02-21 Impact factor: 3.825